Episode 24013
Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
March 27, 202415m 20s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations and risks. Dr. Ang emphasizes the potential of their treatment to revolutionize AML therapy and improve patient outcomes.
Topics
Acute Myeloid Leukemia (AML)Vore BiopharmaCD thirty-three (CD33)Bone marrowCancer cellsChemotherapyStem cell transplantGenetic modificationClinical trialsTreatment innovation